Measuring persistency with drug therapy in glaucoma management

American Journal of Managed Care

Volumn 8, Issue 10 SUPPL., 2002, Pages

  Schwartz, Gail F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; LATANOPROST; TIMOLOL;

COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDITORIAL; GLAUCOMA; GLAUCOMA SURGERY; HEALTH CARE PLANNING; HUMAN; INTRAOCULAR PRESSURE; LONG TERM CARE; MANAGED CARE; MEDICAL DECISION MAKING; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL; VISUAL FIELD;

EID: 0036679470     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Medical management of glaucoma
2. The Advance Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration
3. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures
4. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma
5. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma
6. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss
7. Incidence of open-angle glaucoma: The Barbados Eye Studies
8. Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage
9. Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data
10. Discontinuation rates of topical glaucoma medications in a managed care population
11. Rates of discontinuation and change of glaucoma therapy in a managed care setting